{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 10, "total": 27985 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10003575", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA004510", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA004510" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Drug ineffective", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10003724", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA004552", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA004552" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Drug ineffective", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10003731", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA000828", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA000828" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Erythema", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Pruritus", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Wrong technique in drug usage process", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Product adhesion issue", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugbatchnumb": "3E04WS", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "actiondrug": "5", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } }, { "safetyreportversion": "2", "safetyreportid": "10003934", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141212", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140624", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA002053", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA002053" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Inappropriate schedule of drug administration", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugbatchnumb": "3D07WS", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "HYPERTONIC BLADDER", "drugstartdateformat": "102", "drugstartdate": "20131120", "drugenddateformat": "610", "drugenddate": "201406", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } }, { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosageform": "TRANSDERMAL PATCH", "drugindication": "URINARY INCONTINENCE", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10004062", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1402USA004229", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1402USA004229" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Dermatitis contact", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Application site pruritus", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Application site erythema", "reactionoutcome": "3" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugbatchnumb": "3D03WS", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20131227", "actiondrug": "1", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } }, { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugstartdateformat": "102", "drugstartdate": "20131227", "actiondrug": "1", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10004082", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "3", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "1", "companynumb": "US-ACORDA-ACO_102111_2014", "duplicate": "1", "reportduplicate": { "duplicatesource": "ACORDA", "duplicatenumb": "US-ACORDA-ACO_102111_2014" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientweight": "58.5", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Wrist fracture", "reactionoutcome": "2" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Fall", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Hysterectomy", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Muscular weakness", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Skin discolouration", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Gait disturbance", "reactionoutcome": "3" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "AMPYRA", "drugauthorizationnumb": "022250", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "10 MG, BID", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "GAIT DISTURBANCE", "actiondrug": "5", "openfda": { "application_number": [ "NDA022250" ], "brand_name": [ "AMPYRA" ], "generic_name": [ "DALFAMPRIDINE" ], "manufacturer_name": [ "Merz Pharmaceuticals, LLC" ], "product_ndc": [ "0259-5010", "10144-427" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DALFAMPRIDINE" ], "rxcui": [ "897021", "897025" ], "spl_id": [ "b0f65c2b-ee14-421f-9f24-178e108e38cf", "dda9045d-2f23-412c-9543-74832f421739" ], "spl_set_id": [ "974fb2af-7012-4989-b330-e44a31c9c3e5", "550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783" ], "package_ndc": [ "0259-5010-60", "10144-427-60" ], "nui": [ "N0000192795", "N0000175448" ], "pharm_class_epc": [ "Potassium Channel Blocker [EPC]" ], "pharm_class_moa": [ "Potassium Channel Antagonists [MoA]" ], "unii": [ "BH3B64OKL9" ] } }, { "drugcharacterization": "2", "medicinalproduct": "TYSABRI", "drugdosagetext": "UNK", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugrecurreadministration": "3", "openfda": { "application_number": [ "BLA125104" ], "brand_name": [ "TYSABRI" ], "generic_name": [ "NATALIZUMAB" ], "manufacturer_name": [ "Biogen Inc." ], "product_ndc": [ "64406-008" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS" ], "substance_name": [ "NATALIZUMAB" ], "rxcui": [ "477484", "603541" ], "spl_id": [ "119c87a9-d153-4796-9525-694afdcdc1d6" ], "spl_set_id": [ "c5fdde91-1989-4dd2-9129-4f3323ea2962" ], "package_ndc": [ "64406-008-01" ], "nui": [ "N0000175775", "N0000175774" ], "pharm_class_epc": [ "Integrin Receptor Antagonist [EPC]" ], "pharm_class_moa": [ "Integrin Receptor Antagonists [MoA]" ], "unii": [ "3JB47N2Q2P" ] } }, { "drugcharacterization": "2", "medicinalproduct": "OXYBUTYNIN", "drugdosagetext": "UNK", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugrecurreadministration": "3", "openfda": { "application_number": [ "ANDA202332", "NDA021351", "NDA202211" ], "brand_name": [ "OXYBUTYNIN", "OXYTROL", "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Zydus Pharmaceuticals USA Inc.", "Zydus Lifesciences Limited", "Allergan, Inc." ], "product_ndc": [ "68382-255", "68382-256", "68382-257", "70771-1086", "70771-1087", "70771-1088", "0023-6153", "0023-9637" ], "product_type": [ "HUMAN PRESCRIPTION DRUG", "HUMAN OTC DRUG" ], "route": [ "ORAL", "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN CHLORIDE", "OXYBUTYNIN" ], "rxcui": [ "863619", "863628", "863636", "403799", "404448" ], "spl_id": [ "f54e4d4e-91be-4e10-a446-57ed5e1843a1", "e2d9aa83-078e-4c67-a9d0-8c166bc4d9f0", "12aace89-ecb2-4706-a0bd-5bd24b8db2ed", "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "c042bf06-79a3-4dc7-ae05-3ef3cfae9d44", "f405a774-bd91-4513-b7c7-c44f0596d988", "20dee37f-1412-44ed-9e8b-f4379ce23eb0", "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "68382-255-06", "68382-255-14", "68382-255-16", "68382-255-01", "68382-255-05", "68382-255-30", "68382-255-77", "68382-256-14", "68382-256-01", "68382-256-16", "68382-256-05", "68382-256-30", "68382-256-77", "68382-256-06", "68382-257-14", "68382-257-01", "68382-257-16", "68382-257-05", "68382-257-30", "68382-257-77", "68382-257-06", "70771-1086-3", "70771-1086-6", "70771-1086-9", "70771-1086-1", "70771-1086-5", "70771-1086-2", "70771-1086-4", "70771-1087-6", "70771-1087-1", "70771-1087-9", "70771-1087-5", "70771-1087-3", "70771-1087-2", "70771-1087-4", "70771-1088-6", "70771-1088-1", "70771-1088-9", "70771-1088-5", "70771-1088-3", "70771-1088-2", "70771-1088-4", "0023-6153-08", "0023-9637-04", "0023-9637-08" ], "unii": [ "L9F3D9RENQ", "K9P6MC7092" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VITAMINS", "drugdosagetext": "UNK", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugrecurreadministration": "3" } ] } }, { "safetyreportversion": "1", "safetyreportid": "10004119", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA004538", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA004538" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Drug ineffective", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } }, { "safetyreportversion": "3", "safetyreportid": "10004221", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141212", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140425", "fulfillexpeditecriteria": "1", "companynumb": "US-PFIZER INC-2014070596", "duplicate": "1", "reportduplicate": { "duplicatesource": "PFIZER", "duplicatenumb": "US-PFIZER INC-2014070596" }, "primarysource": { "reportercountry": "US", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "64", "patientonsetageunit": "801", "patientweight": "104.31", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Chest pain", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Palpitations", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Drug ineffective", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "EFFEXOR XR", "drugauthorizationnumb": "020699", "drugstructuredosagenumb": "300", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "300 MG (BY TAKING TWO 150MG ORAL CAPSULE TOGETHER), 1X/DAY", "drugdosageform": "PROLONGED-RELEASE CAPSULE", "drugadministrationroute": "048", "drugindication": "DEPRESSION", "actiondrug": "5", "openfda": { "application_number": [ "NDA020699" ], "brand_name": [ "EFFEXOR XR" ], "generic_name": [ "VENLAFAXINE HYDROCHLORIDE" ], "manufacturer_name": [ "Viatris Specialty LLC" ], "product_ndc": [ "58151-125", "58151-126", "58151-127" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "VENLAFAXINE HYDROCHLORIDE" ], "rxcui": [ "313581", "313583", "313585", "729929", "729931", "729932" ], "spl_id": [ "2319042f-5d24-42d3-9b0a-8893bed66813" ], "spl_set_id": [ "c848a5d8-ba94-4c84-80e3-0bf35fb8e32e" ], "package_ndc": [ "58151-125-93", "58151-125-77", "58151-126-93", "58151-126-77", "58151-127-93", "58151-127-77" ], "unii": [ "7D7RX5A8MO" ] } }, { "drugcharacterization": "1", "medicinalproduct": "EFFEXOR XR", "drugauthorizationnumb": "020699", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugdosagetext": "150 MG, UNK", "drugdosageform": "PROLONGED-RELEASE CAPSULE", "drugadministrationroute": "048", "actiondrug": "5", "openfda": { "application_number": [ "NDA020699" ], "brand_name": [ "EFFEXOR XR" ], "generic_name": [ "VENLAFAXINE HYDROCHLORIDE" ], "manufacturer_name": [ "Viatris Specialty LLC" ], "product_ndc": [ "58151-125", "58151-126", "58151-127" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "VENLAFAXINE HYDROCHLORIDE" ], "rxcui": [ "313581", "313583", "313585", "729929", "729931", "729932" ], "spl_id": [ "2319042f-5d24-42d3-9b0a-8893bed66813" ], "spl_set_id": [ "c848a5d8-ba94-4c84-80e3-0bf35fb8e32e" ], "package_ndc": [ "58151-125-93", "58151-125-77", "58151-126-93", "58151-126-77", "58151-127-93", "58151-127-77" ], "unii": [ "7D7RX5A8MO" ] } }, { "drugcharacterization": "1", "medicinalproduct": "BABY ASPIRIN", "drugdosagetext": "UNK", "drugindication": "CHEST PAIN", "drugstartdateformat": "610", "drugstartdate": "201402", "actiondrug": "5" }, { "drugcharacterization": "2", "medicinalproduct": "OXYBUTYNIN", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "10 MG, 1X/DAY", "drugdosageform": "TABLET", "openfda": { "application_number": [ "ANDA202332", "NDA021351", "NDA202211" ], "brand_name": [ "OXYBUTYNIN", "OXYTROL", "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Zydus Pharmaceuticals USA Inc.", "Zydus Lifesciences Limited", "Allergan, Inc." ], "product_ndc": [ "68382-255", "68382-256", "68382-257", "70771-1086", "70771-1087", "70771-1088", "0023-6153", "0023-9637" ], "product_type": [ "HUMAN PRESCRIPTION DRUG", "HUMAN OTC DRUG" ], "route": [ "ORAL", "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN CHLORIDE", "OXYBUTYNIN" ], "rxcui": [ "863619", "863628", "863636", "403799", "404448" ], "spl_id": [ "f54e4d4e-91be-4e10-a446-57ed5e1843a1", "e2d9aa83-078e-4c67-a9d0-8c166bc4d9f0", "12aace89-ecb2-4706-a0bd-5bd24b8db2ed", "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "c042bf06-79a3-4dc7-ae05-3ef3cfae9d44", "f405a774-bd91-4513-b7c7-c44f0596d988", "20dee37f-1412-44ed-9e8b-f4379ce23eb0", "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "68382-255-06", "68382-255-14", "68382-255-16", "68382-255-01", "68382-255-05", "68382-255-30", "68382-255-77", "68382-256-14", "68382-256-01", "68382-256-16", "68382-256-05", "68382-256-30", "68382-256-77", "68382-256-06", "68382-257-14", "68382-257-01", "68382-257-16", "68382-257-05", "68382-257-30", "68382-257-77", "68382-257-06", "70771-1086-3", "70771-1086-6", "70771-1086-9", "70771-1086-1", "70771-1086-5", "70771-1086-2", "70771-1086-4", "70771-1087-6", "70771-1087-1", "70771-1087-9", "70771-1087-5", "70771-1087-3", "70771-1087-2", "70771-1087-4", "70771-1088-6", "70771-1088-1", "70771-1088-9", "70771-1088-5", "70771-1088-3", "70771-1088-2", "70771-1088-4", "0023-6153-08", "0023-9637-04", "0023-9637-08" ], "unii": [ "L9F3D9RENQ", "K9P6MC7092" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ] } }, { "drugcharacterization": "2", "medicinalproduct": "SIMVASTATIN", "drugstructuredosagenumb": "20", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "20 MG, 1X/DAY", "drugdosageform": "TABLET", "openfda": { "application_number": [ "ANDA078155", "ANDA077691", "ANDA078103", "ANDA200895", "ANDA078034", "ANDA211394", "NDA019766" ], "brand_name": [ "SIMVASTATIN", "ZOCOR" ], "generic_name": [ "SIMVASTATIN" ], "manufacturer_name": [ "Accord Healthcare, Inc.", "NorthStar Rx LLC", "Lupin Pharmaceuticals, Inc.", "XLCare Pharmaceuticals Inc.", "Biocon Pharma Inc,", "Aurobindo Pharma Limited", "Westminster Pharmaceuticals, LLC", "Quallent Pharmaceuticals Health LLC", "Organon LLC", "Camber Pharmaceuticals, Inc." ], "product_ndc": [ "16729-004", "16729-005", "16729-006", "16729-007", "16729-156", "16714-681", "16714-682", "16714-683", "16714-684", "16714-685", "68180-464", "68180-482", "68180-478", "68180-479", "68180-480", "68180-481", "68180-465", "72865-305", "72865-306", "72865-307", "72865-308", "72865-309", "70377-001", "70377-002", "70377-003", "70377-004", "70377-005", "65862-050", "65862-051", "65862-052", "65862-053", "65862-054", "69367-374", "69367-375", "69367-376", "69367-377", "82009-012", "82009-013", "82009-014", "82009-015", "82009-016", "78206-180", "78206-182", "78206-181", "31722-510", "31722-511", "31722-512", "31722-513", "31722-514" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "SIMVASTATIN" ], "rxcui": [ "198211", "200345", "312961", "312962", "314231", "104490", "104491", "152923" ], "spl_id": [ "43910ff2-6a21-bf9e-e063-6294a90a3f5c", "6c353eba-27f3-43cc-b954-ec659881872f", "b78d4e8a-2261-43c6-9321-ac2539bdfd2f", "48bd010d-6429-906e-e063-6394a90ae8b7", "4d832ba0-8b5c-de5a-246a-a5f30e884bb4", "854ac8f7-cca5-434c-a611-9c1752260d4a", "5bcccfd7-0ae8-4fad-a535-5efa7b327550", "1de47781-9000-0fc1-e063-6294a90a8139", "11256523-425c-48e8-afe1-e3a4e28c892e", "1553d57f-414d-2c66-e063-6294a90af8e0" ], "spl_set_id": [ "871251c0-36a1-4a32-9eab-ff6c1e925ca9", "0376351b-f1a0-43e5-a0b4-533072c49f39", "3e48217f-8175-4e9b-9fd0-909be4bbba95", "433f8a86-5ad3-43db-8e62-c0812dd3d723", "7b325108-6940-50a7-96b4-822a5206e568", "4724dbb4-3613-4e6a-948f-a43d34f97f06", "acaaab63-c9ff-44c9-8fde-9a4ea6454dd7", "2b4255a7-f9f5-4235-8dbb-b0f03acbd624", "8f55d5de-5a4f-4a39-8c84-c53976dd6af9", "751b79c6-bba8-4d29-b69c-a2ac6453fec8" ], "package_ndc": [ "16729-005-10", "16729-005-12", "16729-005-15", "16729-005-17", "16729-006-10", "16729-006-12", "16729-006-15", "16729-006-17", "16729-007-10", "16729-007-12", "16729-007-15", "16729-007-17", "16729-156-10", "16729-156-15", "16729-156-17", "16729-004-10", "16729-004-12", "16729-004-15", "16729-004-17", "16714-681-01", "16714-681-02", "16714-682-01", "16714-682-02", "16714-682-03", "16714-683-01", "16714-683-02", "16714-683-03", "16714-684-01", "16714-684-02", "16714-684-03", "16714-685-01", "16714-685-02", "16714-685-03", "68180-482-09", "68180-482-06", "68180-482-03", "68180-482-11", "68180-478-02", "68180-478-03", "68180-478-01", "68180-479-02", "68180-479-03", "68180-479-01", "68180-480-01", "68180-480-02", "68180-480-03", "68180-481-01", "68180-481-03", "68180-481-02", "68180-464-06", "68180-464-09", "68180-464-03", "68180-465-06", "68180-465-09", "68180-465-03", "72865-305-30", "72865-305-01", "72865-305-10", "72865-305-90", "72865-306-30", "72865-306-01", "72865-306-10", "72865-306-90", "72865-307-30", "72865-307-01", "72865-307-10", "72865-307-90", "72865-307-45", "72865-308-30", "72865-308-01", "72865-308-10", "72865-308-90", "72865-308-45", "72865-309-30", "72865-309-01", "72865-309-05", "72865-309-90", "72865-309-45", "72865-309-10", "70377-001-13", "70377-001-14", "70377-001-15", "70377-001-12", "70377-002-12", "70377-002-13", "70377-002-14", "70377-002-15", "70377-003-12", "70377-003-13", "70377-003-14", "70377-003-15", "70377-004-12", "70377-004-13", "70377-004-14", "70377-004-15", "70377-005-12", "70377-005-13", "70377-005-14", "70377-005-15", "65862-050-30", "65862-050-45", "65862-050-90", "65862-050-01", "65862-050-00", "65862-050-99", "65862-050-26", "65862-051-30", "65862-051-45", "65862-051-90", "65862-051-01", "65862-051-00", "65862-051-99", "65862-051-26", "65862-052-30", "65862-052-45", "65862-052-90", "65862-052-01", "65862-052-00", "65862-052-99", "65862-052-26", "65862-053-30", "65862-053-45", "65862-053-90", "65862-053-01", "65862-053-00", "65862-053-99", "65862-053-22", "65862-054-30", "65862-054-45", "65862-054-90", "65862-054-00", "65862-054-99", "65862-054-39", "69367-374-09", "69367-374-10", "69367-375-09", "69367-375-10", "69367-376-09", "69367-376-10", "69367-377-09", "69367-377-10", "82009-013-10", "82009-012-10", "82009-014-10", "82009-015-10", "82009-016-05", "78206-182-01", "78206-182-02", "78206-181-02", "78206-181-01", "78206-180-01", "78206-180-02", "31722-510-30", "31722-510-01", "31722-510-10", "31722-510-90", "31722-511-30", "31722-511-01", "31722-511-10", "31722-511-90", "31722-512-30", "31722-512-01", "31722-512-10", "31722-512-90", "31722-513-30", "31722-513-01", "31722-513-10", "31722-513-90", "31722-514-30", "31722-514-01", "31722-514-05", "31722-514-90" ], "nui": [ "N0000175589", "N0000000121" ], "pharm_class_epc": [ "HMG-CoA Reductase Inhibitor [EPC]" ], "pharm_class_moa": [ "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]" ], "unii": [ "AGG2FN16EV" ] } } ] } }, { "safetyreportversion": "3", "safetyreportid": "10004320", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141212", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140528", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA000829", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA000829" }, "primarysource": { "reportercountry": "US", "qualification": "1" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientweight": "58.96", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Purulent discharge", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Scab", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Skin irritation", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Application site erythema", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Rash", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Dermatitis", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Rash", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugbatchnumb": "3C02WS", "drugauthorizationnumb": "202211", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "032", "drugdosagetext": "1 DF, Q4D", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "POLLAKIURIA", "drugstartdateformat": "102", "drugstartdate": "20131229", "drugenddateformat": "102", "drugenddate": "20140208", "actiondrug": "5", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } }, { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosageform": "TRANSDERMAL PATCH", "drugindication": "HYPERTONIC BLADDER", "actiondrug": "5", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VIVACTIL", "drugdosagetext": "UNK, UNKNOWN", "drugindication": "DEPRESSION", "actiondrug": "5" }, { "drugcharacterization": "2", "medicinalproduct": "CHOLECALCIFEROL", "drugdosagetext": "UNK, UNKNOWN", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "actiondrug": "5" }, { "drugcharacterization": "2", "medicinalproduct": "ASCORBIC ACID", "drugdosagetext": "UNK, UNKNOWN", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "actiondrug": "5", "openfda": { "application_number": [ "ANDA217131", "NDA209112", "505G(a)(3)" ], "brand_name": [ "ASCORBIC ACID", "ASCOR", "SKIN RENEWING SERUM" ], "generic_name": [ "ASCORBIC ACID" ], "manufacturer_name": [ "Fresenius Kabi USA, LLC", "McGuff Pharmaceuticals, Inc.", "Guangzhou Danting Bath&Body Care Industry Co. Ltd" ], "product_ndc": [ "65219-027", "67157-101", "75376-102" ], "product_type": [ "HUMAN PRESCRIPTION DRUG", "HUMAN OTC DRUG" ], "route": [ "INTRAVENOUS", "TOPICAL" ], "substance_name": [ "ASCORBIC ACID" ], "rxcui": [ "308395", "2002739", "199834" ], "spl_id": [ "d6fd1a37-70e1-477a-afc9-4977a54c7b75", "52fac578-887d-7374-e063-6294a90a7eb9", "3d07e83d-f311-0fa9-e063-6394a90a3b0b" ], "spl_set_id": [ "1606e29f-0e80-4069-b688-daab9cbff20a", "388aad52-fc01-4784-9791-1dbc80c69306", "396c2a8d-ac95-cbef-e063-6294a90aff39" ], "package_ndc": [ "65219-027-55", "65219-027-05", "65219-027-50", "67157-101-50", "67157-101-51", "75376-102-30" ], "nui": [ "N0000193618", "M0001797" ], "pharm_class_epc": [ "Vitamin C [EPC]" ], "pharm_class_cs": [ "Ascorbic Acid [CS]" ], "unii": [ "PQ6CK8PD0R" ] } }, { "drugcharacterization": "2", "medicinalproduct": "DESOXIMETASONE", "drugdosagetext": "UNK, UNKNOWN", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "actiondrug": "5", "openfda": { "application_number": [ "ANDA206792", "ANDA205206", "ANDA202838", "ANDA205620", "ANDA208164", "ANDA208044", "ANDA208124", "ANDA077770", "ANDA208163", "ANDA208104", "ANDA074286", "NDA018594", "ANDA203234", "ANDA076510", "NDA204141", "ANDA206441", "ANDA074904", "ANDA073193", "ANDA073210", "ANDA209973", "ANDA203787", "ANDA204965" ], "brand_name": [ "DESOXIMETASONE", "TOPICORT" ], "generic_name": [ "DESOXIMETASONE" ], "manufacturer_name": [ "Novel Laboratories, Inc.", "Viona Pharmaceuticals Inc", "Zydus Lifesciences Limited", "Glenmark Pharmaceuticals Inc., USA", "Lupin Pharmaceuticals, Inc.", "Padagis Israel Pharmaceuticals Ltd", "Sun Pharmaceutical Industries, Inc.", "Saptalis Pharmaceuticals, LLC.", "The J. Molner Company LLC", "Actavis Pharma, Inc." ], "product_ndc": [ "40032-024", "72578-095", "70771-1166", "68462-531", "72578-091", "70771-1437", "68180-950", "68180-948", "68180-944", "45802-496", "68180-949", "68180-946", "51672-1262", "51672-1352", "71656-087", "45802-495", "51672-5263", "51672-1396", "51672-5281", "45802-807", "51672-1261", "51672-1271", "51672-1270", "83148-021", "71656-086", "0472-0479" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "TOPICAL" ], "substance_name": [ "DESOXIMETASONE" ], "rxcui": [ "197575", "197574", "141850", "1376338", "197573", "1050394", "1376340", "315059" ], "spl_id": [ "e89ba1da-1104-4402-b0c5-e5afe8373eea", "a4b291f3-d49c-4ff0-b79d-dba724f45037", "a0f8637b-17be-4fae-b1cf-f485589f66fb", "15a31bdf-5162-42bd-a3d5-7e21bac5f49f", "af1f6394-c7b7-41be-bf5e-d0cc7f0da19b", "0e9fa124-ac31-45e8-a61b-1301bf32b25a", "12e78382-d657-47a3-8fba-eb3e5c6270dc", "09c8e716-9202-46d9-bb9a-1ef1d18a74d8", "d14663a1-48bd-4a69-9c72-80f84a14fc85", "3b8c8718-4be4-4a05-9cf0-f2f4430c675e", "f04119f4-6a51-4129-beeb-5b0436e9ab8a", "5752644f-f41f-4d69-9f97-ef3818fd482a", "390832c6-f29f-e683-e063-6394a90a2484", "390c5ade-f985-c789-e063-6294a90a6d9f", "513a7c3c-05ee-9414-e063-6394a90a3500", "00b7b683-69a7-48cc-8286-67288e91c859", "4cd6638c-db25-e28b-e063-6294a90a4a9a", "39702ff5-c8de-79c1-e063-6294a90a6dfa", "38f9cadb-290c-0c68-e063-6394a90a38d9", "f901679b-60ff-48f1-95b7-7114fc83e9fc", "38f63e0c-c4d2-523e-e063-6394a90a0272", "40294484-39af-a667-e063-6394a90ab281", "518f7202-620a-0117-e063-6394a90ac9f3", "01addff4-d328-41d9-8e13-42f20819c2e9" ], "spl_set_id": [ "781a7bba-b00d-4ceb-aefe-74c73d263b67", "f8e213a9-5e80-45e2-834c-7734dd39c1ac", "959e396a-2458-43b5-b412-db1974d58d8d", "ea742af6-9359-46c3-9164-ab53e8c1461e", "309a93de-ce89-4244-959a-3236d5e95c06", "b780701b-5572-48bc-a5f4-00248eaddd3b", "f53ddb86-bf8a-4bb3-b7ce-387fa78d9066", "b53727cf-a57f-443f-8036-3d4bd2737540", "e4b648f4-c65d-44b3-a97a-657730f65322", "4025ed23-a591-4754-8dbb-4da18f49a3e3", "da2a8a3e-f187-4906-8fe3-246cc31de16f", "65e5f3c5-ef24-4e21-9427-fa0d5c283098", "627031fc-9b91-4854-b08f-f9fc0c73f1de", "96898d55-aa50-4281-8c23-ec4738ede394", "c84c7168-3d46-4e05-a25c-3d594ff94268", "4ad6c159-4daa-4a33-8db6-351b5263323d", "96dfac6f-540f-4b7d-bcee-7e62088ebc93", "b046ab97-ba1a-4be6-a238-09670b38b397", "e417856a-b760-4626-bc34-8e4bc62c026c", "dc104fb8-4d7c-4bed-b2d8-8d9cfe8f0e5b", "37eb1205-1743-4480-8631-b0bbcaeb8359", "2bbb5200-8355-ba86-e063-6394a90a23b6", "827aee22-cf48-477c-8791-c74f16da954d", "c342beac-547b-4b0b-a39c-44a0961f924b" ], "package_ndc": [ "40032-024-60", "40032-024-61", "72578-095-01", "72578-095-02", "72578-095-03", "70771-1166-1", "70771-1166-3", "70771-1166-0", "68462-531-17", "68462-531-65", "72578-091-01", "72578-091-02", "72578-091-03", "70771-1437-1", "70771-1437-3", "70771-1437-0", "68180-950-01", "68180-950-02", "68180-950-04", "68180-948-04", "68180-948-01", "68180-948-02", "68180-948-06", "68180-944-33", "68180-944-11", "68180-944-22", "45802-496-14", "45802-496-96", "68180-949-02", "68180-949-04", "68180-949-01", "68180-946-01", "68180-946-04", "68180-946-02", "68180-946-06", "51672-1262-1", "51672-1262-2", "51672-1262-3", "51672-1262-7", "51672-1352-1", "51672-1352-2", "51672-1352-3", "51672-1352-7", "71656-087-15", "71656-087-60", "45802-495-35", "45802-495-37", "51672-5263-5", "51672-5263-1", "51672-5263-2", "51672-5263-3", "51672-5263-7", "51672-1396-3", "51672-1396-4", "51672-1396-7", "51672-1396-6", "51672-5281-0", "51672-5281-3", "51672-5281-4", "51672-5281-7", "51672-5281-6", "45802-807-98", "51672-1271-1", "51672-1271-2", "51672-1271-3", "51672-1271-7", "51672-1270-1", "51672-1270-2", "51672-1270-3", "51672-1270-7", "51672-1261-1", "51672-1261-2", "51672-1261-3", "83148-021-60", "83148-021-99", "71656-086-15", "71656-086-60", "0472-0479-15", "0472-0479-60" ], "nui": [ "N0000175576", "N0000175450" ], "pharm_class_epc": [ "Corticosteroid [EPC]" ], "pharm_class_moa": [ "Corticosteroid Hormone Receptor Agonists [MoA]" ], "unii": [ "4E07GXB7AU" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10004361", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-009507513-1403USA005911", "duplicate": "1", "reportduplicate": { "duplicatesource": "MERCK", "duplicatenumb": "US-009507513-1403USA005911" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Wrong technique in drug usage process", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Product adhesion issue", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "OXYTROL FOR WOMEN", "drugauthorizationnumb": "202211", "drugdosagetext": "UNK, UNKNOWN", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "NDA202211" ], "brand_name": [ "OXYTROL FOR WOMEN" ], "generic_name": [ "OXYBUTYNIN" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0023-9637" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "OXYBUTYNIN" ], "rxcui": [ "403799", "404448" ], "spl_id": [ "cc404430-2345-4294-8efc-e1e996cc17b2" ], "spl_set_id": [ "8cdc5b4d-ff8d-4010-97d7-313422a0b868" ], "package_ndc": [ "0023-9637-04", "0023-9637-08" ], "nui": [ "N0000175700", "N0000000125" ], "pharm_class_epc": [ "Cholinergic Muscarinic Antagonist [EPC]" ], "pharm_class_moa": [ "Cholinergic Muscarinic Antagonists [MoA]" ], "unii": [ "K9P6MC7092" ] } } ] } } ] }